Click on image to view larger version.

Figure 1 Kaplan-Meier event-free survival to 9 months for patients treated with zotarolimus- (ZES) and sirolimus-eluting (SES) stents. MACE = major adverse cardiac events; TLR = target lesion revascularization; TVF = target vessel failure.